Medy Tox (Korea) Price Prediction
086900 Stock | KRW 129,100 300.00 0.23% |
Oversold Vs Overbought
22
Oversold | Overbought |
Using Medy Tox hype-based prediction, you can estimate the value of Medy Tox from the perspective of Medy Tox response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Medy Tox to buy its stock at a price that has no basis in reality. In that case, they are not buying Medy because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Medy Tox after-hype prediction price | KRW 129100.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Medy |
Medy Tox After-Hype Price Prediction Density Analysis
As far as predicting the price of Medy Tox at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Medy Tox or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Medy Tox, with the unreliable approximations that try to describe financial returns.
Next price density |
Expected price to next headline |
Medy Tox Estimiated After-Hype Price Volatility
In the context of predicting Medy Tox's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Medy Tox's historical news coverage. Medy Tox's after-hype downside and upside margins for the prediction period are 129,097 and 129,103, respectively. We have considered Medy Tox's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Medy Tox is very steady at this time. Analysis and calculation of next after-hype price of Medy Tox is based on 3 months time horizon.
Medy Tox Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Medy Tox is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Medy Tox backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Medy Tox, there might be something going there, and it might present an excellent short sale opportunity.
Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.68 | 3.43 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
129,100 | 129,100 | 0.00 |
|
Medy Tox Hype Timeline
Medy Tox is presently traded for 129,100on KOSDAQ of Korea. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Medy is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at -0.68%. %. The volatility of related hype on Medy Tox is about 0.0%, with the expected price after the next announcement by competition of 129,100. About 27.0% of the company shares are owned by insiders or employees . The company recorded earning per share (EPS) of 1813.31. Medy Tox had not issued any dividends in recent years. The entity had 21:20 split on the 28th of December 2022. Assuming the 90 days trading horizon the next forecasted press release will be in 5 to 10 days. Check out Medy Tox Basic Forecasting Models to cross-verify your projections.Medy Tox Related Hype Analysis
Having access to credible news sources related to Medy Tox's direct competition is more important than ever and may enhance your ability to predict Medy Tox's future price movements. Getting to know how Medy Tox's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Medy Tox may potentially react to the hype associated with one of its peers.
HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
086900 | Medy Tox | 0.00 | 0 per month | 0.00 | (0.21) | 5.32 | (4.34) | 20.46 | |
011390 | Busan Industrial Co | 0.00 | 0 per month | 2.39 | (0.0003) | 4.70 | (4.61) | 24.98 | |
011390 | Busan Ind | 0.00 | 0 per month | 2.39 | (0.0003) | 4.70 | (4.61) | 24.98 | |
006805 | Mirae Asset Daewoo | 0.00 | 0 per month | 1.67 | 0.01 | 1.44 | (2.55) | 37.44 | |
036200 | UNISEM Co | 0.00 | 0 per month | 0.00 | (0.15) | 6.07 | (4.11) | 16.12 | |
133820 | Finebesteel | 0.00 | 0 per month | 1.90 | 0.03 | 3.59 | (2.87) | 25.82 | |
133820 | Fine Besteel Co | 0.00 | 0 per month | 1.90 | 0.03 | 3.59 | (2.87) | 25.82 | |
267250 | Hyundai Heavy Industries | 0.00 | 0 per month | 2.18 | (0.06) | 2.80 | (3.21) | 9.29 | |
012450 | Hanwha Aerospace Co | 0.00 | 0 per month | 2.97 | 0.05 | 7.04 | (5.40) | 23.30 |
Medy Tox Additional Predictive Modules
Most predictive techniques to examine Medy price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Medy using various technical indicators. When you analyze Medy charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About Medy Tox Predictive Indicators
The successful prediction of Medy Tox stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Medy Tox, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Medy Tox based on analysis of Medy Tox hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Medy Tox's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Medy Tox's related companies.
Story Coverage note for Medy Tox
The number of cover stories for Medy Tox depends on current market conditions and Medy Tox's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Medy Tox is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Medy Tox's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Medy Tox Short Properties
Medy Tox's future price predictability will typically decrease when Medy Tox's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Medy Tox often depends not only on the future outlook of the potential Medy Tox's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Medy Tox's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 6.1 M | |
Cash And Short Term Investments | 81.9 B |
Complementary Tools for Medy Stock analysis
When running Medy Tox's price analysis, check to measure Medy Tox's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medy Tox is operating at the current time. Most of Medy Tox's value examination focuses on studying past and present price action to predict the probability of Medy Tox's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medy Tox's price. Additionally, you may evaluate how the addition of Medy Tox to your portfolios can decrease your overall portfolio volatility.
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |